cabazitaxel interferes with the normal process of cell division, leading to the death of cancer cells. The drug stabilizes microtubules, which play a crucial role in cell division. By stabilizing microtubules, cabazitaxel slows down the cell division rate and prevents cancer cell growth.
cabazitaxel is primarily used to treat advanced or metastatic prostate cancer that is not responding to other chemotherapy drugs. The medication is active against many prostate cancer cells, including those resistant to other chemotherapy drugs.